EDGAR Filing Documents for 0001144204-19-043819

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001144204-19-043819

Filing Date

2019-09-06

Accepted

2019-09-06 17:07:15

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	tv529001_424b3.htm	424B3	513416
2	GRAPHIC	logo-1.gif	GRAPHIC	3961
	Complete submission text file	0001144204-19-043819.txt		520029

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 424B3 | Act: 33 | File No.: 333-233048 | Film No.: 191080317
SIC: 2834 Pharmaceutical Preparations